• Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 07 Oct 2024 02:26:10   America/Chicago


    Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat October 7, 2024 Share Link copied to clipboard. Shares of Apellis Pharmaceuticals, Inc.
    Read more...
Share on,